Prosecution Insights
Last updated: April 19, 2026

Parithosh K. Tungaturthi

9 pending office actions • 6 clients

Portfolio Summary

9
Total Pending OAs
0
Final Rejections
9
Non-Final OAs

Client Portfolio (6 clients)

Client (Assignee)Pending OAs
Msn Laboratories Private Limited, R&D Center 3
Msn Laboratories Private Ltd., R&D Center 1
Omniactive Health Technologies Limited 1
Aurigene Discovery Technologies Limited 1
Transdermal Delivery Solutions Corp. 1
Msn Laboratories Private Limited, R & D Center 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18293752 COMPOSITION COMPRISING PHOTOSENSITZER COMPOUND AND ACTIVATION THEREOF Unknown PIPIC, ALMA 1617 Non-Final OA Jan 30, 2024
18579826 NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE Msn Laboratories Private Ltd., R&D Center SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Jan 16, 2024
18566653 BERBERIS COMPOSITION FOR COGNITIVE HEALTH Omniactive Health Technologies Limited HOFFMAN, SUSAN COE 1655 Non-Final OA Dec 03, 2023
18564611 AN IMPROVED PROCESS FOR THE PREPARATION OF (4R)-1-[(2R,4R,5R)-3,3-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL) OXOLAN-2-YL]-4-HYDROXY-1,3-DIAZINAN-2ONE AND ITS INTERMEDIATE COMPOUNDS Msn Laboratories Private Limited, R&D Center MILLER, DALE R 1693 Non-Final OA Nov 28, 2023
18548119 NOVEL PROCESS FOR THE PREPARATION OF 2,5-DICHLORO-3-(5-(3,4-DIHYDROXY-5-NITROPHENYL)-1,2,4-OXADIAZOL-3-YL)-4,6-DIMETHYLPYRIDINE-1-OXIDE Msn Laboratories Private Limited, R&D Center HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Aug 28, 2023
18264076 SUBSTITUTED PYRAZOLYL COMPOUNDS AS MALT-1 INHIBITORS Aurigene Discovery Technologies Limited O DELL, DAVID K 1621 Non-Final OA Aug 03, 2023
18252882 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF Msn Laboratories Private Limited, R&D Center CHANDRAKUMAR, NIZAL S 1625 Non-Final OA May 14, 2023
18028036 TRANSDERMAL INSULIN FORMULATIONS AND METHODS OF USE THEREOF Transdermal Delivery Solutions Corp. CHANDRA, GYAN 1674 Non-Final OA Mar 23, 2023
17918911 PHARMACEUTOCAL COMPOSITION CONTAINING N-(4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-N?-(4­FLUOROPHENLY)CYCLOPROPANE-1,1-DICARBOXAMIDE, (2S)-HYDROXYBUTANEDIOATE Msn Laboratories Private Limited, R & D Center LADD, CAROLYN LOUISE 1622 Non-Final OA Oct 14, 2022

Managing Parithosh K. Tungaturthi's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month